David Sinclair, Ph.D.

Co-Director, Paul F. Glenn Labs for the Biology of Aging

Professor of Genetics, Harvard Medical School

Longevity, Biology of Aging


BS - University of New South Wales

PhD - University of New South Wales

Post-Doctoral Fellow - Massachusetts Institute of Technology


Time Magazine’s 100, 2014

Director’s Pioneer Award, NIH, 2017

The Irving Wright Award, American Federation for Aging, 2018

Genzyme Outstanding Achievement in Biomedical Science Award

Nathan Shock Award, NIH

Bio-Innovator Award

New York Time Best Selling Author for “Lifespan: Why We Age - and Why We Don’t Have To”

Australian Medical Research Medal, 2014

Officer of the Order of Australia, 2018


Co-Founder: Sirtris Pharmaceuticals (acquired by GlaxoSmithKline), Life Biosciences, Genocea Bioscience (NASDAQ:GNCA), CohBar (NASDAQ:CWBR), MetroBiotech, Arc Bio, Liberty Biosecurity, Senolytic Therapeutics, Spotlight Biosciences, Iduna, Immetas, Jumpstart Fertility, Continuum Biosciences, Revere Biosensors

Scientific Advisory Board: Jupiter Orphan Therapeutics, Zymo Research, Elysium Health, InsideTracker

MEMBER OF Investment Committee

Associated Portfolio Companies

No items found.